Atlas Trials

To Explore the Effect of Immune-induced Stereotactic Body Radiotherapy (SBRT) on Reversing Immunoresistance in Stage IIIc/IV Non-small Cell Lung Cancer (NSCLC)

Clinical trial NCT06154967 · UNKNOWN

Trial details

NCT number
NCT06154967
Sponsor
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Non-Small Cell Lung Cancer Without Mutation in Epidermal Growth Factor Receptor (Disorder)
Start date
2024-01-01
Primary completion
2025-06-30
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.